Steven M Blum

7PUBLICATIONS
80CO-AUTHORS
Tumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Natural language processingPredictive and prognostic markersCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Aug 07, 2026
Spatial organisation of tumor-infiltrating B-cells informs immune checkpoint inhibitor response in Claudin 18.2-expressing gastric cancer.

|May 16, 2025
Tumor location as a risk factor for severe immune-related adverse events.

Steven M Blum, Ben Ouyang, Leyre Zubiri

|Sep 03, 2024
Enhancing Precision in Detecting Severe Immune-Related Adverse Events: Comparative Analysis of Large Language Models and International Classification of Disease Codes in Patient Records.

Virginia H Sun, Julius C Heemelaar, Ibrahim Hadzic

|Nov 24, 2023
Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer.

Sujin Hyung, Jihoon Ko, You Jeong Heo

|Aug 14, 2023
Effects of immune-related adverse events (irAEs) and their treatment on antitumor immune responses.

Steven M Blum, Sherin J Rouhani, Ryan J Sullivan

|Sep 21, 2021
Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer.

Leyre Zubiri, Gabriel E Molina, Meghan J Mooradian

Pageof 2

Frequent Collaborators

3 joint publications

Michael Dougan

3 joint publications

Leyre Zubiri

2 joint publications

Ryan J Sullivan

2 joint publications

Meghan J Mooradian